1. Background {#sec1}
=============

An elevated lactate level is a well-known predictor of organ dysfunction and mortality in critically ill patients \[[@B1]--[@B10]\]. The pathways for glucose and lactate metabolism are deeply interconnected. In the Cori cycle, glucose can be converted to lactate though glycolysis and lactate can generate glucose through gluconeogenesis, indicating that glucose can greatly influence lactate metabolism and vice versa. In this regard, blood glucose levels may be a confounder in the association between high lactate levels and increased mortality in ICU patients. Some studies have demonstrated the associations of glucose level and lactate level with the risk of death \[[@B1], [@B3], [@B5], [@B7]--[@B17]\]. A recent study has shown that a low glucose level combined with a high lactate level was associated with the highest mortality of ICU patients \[[@B11]\]. However, whether glucose levels influence the predictive value of lactate for hospital mortality in critically ill patients remained largely unknown. Herein, we conducted a study to investigate the predictive ability of lactate at various glucose levels. Specifically, we hypothesized that glucose levels could modify the association between high lactate levels and increased mortality in critically ill patients. We aimed to get a more comprehensive appreciation and a more accurate prediction strategy of using lactate as a prognostic biomarker to assess the outcomes of ICU patients.

2. Methods {#sec2}
==========

2.1. Patients and Data Sources {#sec2.1}
------------------------------

We conducted a retrospective study of 293 patients older than 18 years of age admitted to the intensive care unit (ICU) of The First Affiliated Hospital of Xi\'an Jiaotong University from June 2013 to Dec 2016. The study was approved by the medical ethics committee of Xi\'an Jiaotong University. The patient\'s informed written consent was waived due to the retrospective nature of this study. Anonymized patient information was obtained from the hospital\'s electronic patient database. The following data were recorded from the electronic medical record: demographics, comorbidities, initial and worst vital signs, and laboratory measurements. The APACHE II score, SOFA score, and qSOFA score were calculated according to References \[[@B18]--[@B20]\]. Renal dysfunction was defined by the presence of acute kidney injury (AKI) according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria \[[@B21]\].

2.2. Statistical Analysis {#sec2.2}
-------------------------

Continuous data was tested for normality by the Kolmogorov-Smirnov test. Normal distribution variables are reported as the means ± standard deviations (SD) and compared by Student\'s *t*-test. Abnormal distribution variables are reported as the medians (interquartile range (IQR)) and compared by the Mann--Whitney rank-sum test. Categorical variables are reported as the numbers and percentages and compared by the chi-squared analysis or Fisher\'s exact test. *p* \< 0.05 was considered to be statistically significant. The logistic regression analysis and the area under the receiver operating characteristic curve (AUROC) were applied to evaluate the predictive ability of lactate. All statistics analyses were performed using IBM SPSS version 23.0 for Windows (IBM, Chicago, Ill., United States).

3. Results {#sec3}
==========

3.1. Patient Characteristics {#sec3.1}
----------------------------

We analyzed the data of 293 patients admitted to the ICU between June 2013 and Dec 2016. Of these patients, 59 (20.1%) died during hospital stay. Patient characteristics of hospital survivors and nonsurvivors are shown in [Table 1](#tab1){ref-type="table"}. There were no statistically significant differences in age, gender, and reason for ICU admission between survivors and nonsurvivors. In terms of comorbidities, the deceased patients were more likely to have diabetes mellitus and multiple organ failure (MOF) than survivors. In addition, the lactate level, SOFA score, and APACHE II score at ICU admission were significantly higher in nonsurvivors than in survivors. However, there was no significant difference in blood glucose levels between the hospital survivors and nonsurvivors.

3.2. Associations of Patient\'s Clinical Characteristics and Predictive Scores with In-Hospital Mortality {#sec3.2}
---------------------------------------------------------------------------------------------------------

We firstly conducted univariable logistic regression analysis to investigate the associations of patients\' clinical characteristics and predictive scores (including lactate level, glucose level, SOFA score, APACHE II score, and qSOFA score) with in-hospital mortality. As shown in [Table 2](#tab2){ref-type="table"}, patients\' age, gender, and reason for ICU admission were unassociated with in-hospital mortality. Among 15 various comorbidities, patients with diabetes mellitus and patients with MOF correlated significantly with higher in-hospital mortality. Among the five predictive scores, lactate level, SOFA score, APACHE II score, and qSOFA score were strongly associated with in-hospital mortality whereas the glucose level was not associated with in-hospital mortality. We further conducted a multivariate logistic regression analysis using the parameters shown to have statistical significance by univariate analysis. As a result, only diabetes mellitus, APACHE II, and lactate level were correlated significantly with higher in-hospital mortality.

The receiver operating characteristic (ROC) curve was also applied in our study to assess the mortality prediction performance of the five predictive scores. As seen in [Figure 1](#fig1){ref-type="fig"}, the AUROC of lactate level, glucose level, APACHE II score, SOFA score, and qSOFA score were 0.678, 0.472, 0.675, 0.736, and 0.605, respectively. The AUROC of lactate was the second largest and comparable to that of the SOFA score. The calculated cutoff for lactate to predict in-hospital mortality was 1.45 mmol/L. The AUROC of glucose, on the other hand, was much lower than that of the other four scores.

3.3. Glucose Levels Influence the Predictive Ability of Lactate {#sec3.3}
---------------------------------------------------------------

It has been reported that the glucose showed a U-shaped characteristic in a number of illnesses \[[@B12], [@B19]\]. The "safe range" of glucose has been defined between 7.0 mmol/L and 9.0 mmol/L (the conversion factor of glucose is 1 mmol/L = 18 mg/dL) in critically ill patients \[[@B11], [@B12]\]. Following these criteria, we divided the 293 patients into three groups based on the glucose levels: low-glucose group (glucose \< 7 mmol/L), medium-glucose group (glucose: 7-9 mmol/L), and high-glucose group (glucose \> 9 mmol/L). Each group was further divided into two subgroups based on lactate cutoff point as shown in [](#supplementary-material-1){ref-type="supplementary-material"} (i.e., 1.45 mmol/L; the conversion factor of lactate is 1 mmol/L = 9 mg/dL). The association of lactate levels with in-hospital mortality and the predictive ability of lactate were investigated in this scenario. As seen in [Figure 2](#fig2){ref-type="fig"}, the highest mortality was observed in the group with the lowest glucose level and the highest lactate level. The lactate level was associated with in-hospital mortality in the low- and high-glucose groups (*p* \< 0.001), but not in the medium-glucose group ([Table 3](#tab3){ref-type="table"}). The AUROC of lactate in the three glucose groups were 0.723, 0.603, and 0.677, respectively. The AUROC of lactate in the medium-glucose group was also the lowest among the three ([Figure 3](#fig3){ref-type="fig"}).

3.4. APACHE II Score and SOFA Score Could Be Utilized as an Alternative Predictor of Hospital Mortality in the Medium-Glucose Group {#sec3.4}
-----------------------------------------------------------------------------------------------------------------------------------

In addition to lactate, the association between patients\' clinical characteristics and other predictive scores (including APACHE II score, SOFA score, and qSOFA score) with in-hospital mortality in the three glucose groups was also investigated. As seen in [Table 3](#tab3){ref-type="table"}, only the SOFA score and APACHE II score were clearly associated with higher in-hospital mortality in all three glucose groups whereas the association of other indexes with mortality was influenced by glucose levels. The ROC and AUROC of the SOFA score, APACHE II score, and qSOFA score were also plotted and compared with that of lactate as show in [Figure 4](#fig4){ref-type="fig"}. In the medium-glucose group where the lactate level was unassociated with in-hospital mortality, the APACHE II score presented the largest AUROC, followed by the SOFA score, qSOFA, score and lactate.

4. Discussion {#sec4}
=============

In this study, we demonstrated that glucose levels could influence the association between lactate and in-hospital mortality in critically ill patients. Specifically, in the low- (less than 7 mmol/L) and high- (more than 9 mmol/L) glucose groups, lactate was strongly associated with in-hospital mortality and could provide a good performance in predicting in-hospital mortality. In the medium-glucose group (between 7 mmol/L and 9 mmol/L), however, lactate was unassociated with in-hospital mortality and its predictive ability reduced significantly. Moreover, we also demonstrated that the APACHE II score and SOFA score were correlated with higher in-hospital mortality in all three glucose groups. Therefore, in patients with glucose levels between 7 and 9 mmol/L where the lactate level was inadequate to predict in-hospital mortality, the SOFA score and APACHE II score could be utilized as alternative indexes in order to achieve a more accurate prediction.

Glucose and lactate intervene in a very complex way in a series of glycometabolic pathways and play important roles in glycometabolic related diseases. Plenty of observational studies have demonstrated that the glucose level during ICU admission was related to mortality by a U-shaped curve \[[@B11], [@B12]\]. Both hyperglycemia and hypoglycemia had an increased risk of death and were associated with an increase in the ICU length of stay \[[@B13]--[@B16]\]. The "safe range" of glucose has been defined between 7.0 and 9.0 mmol/L which is within the optimal blood glucose concentration (BGC) target range (NICE-SUGAR protocol) \[[@B12], [@B13]\]. The mean glucose values between 7.0 and 9.0 mmol/L during ICU stay were associated with the lowest OR for mortality at the ICU, while the mean values below 7.0 and higher than 9.0 mmol/L conferred significantly higher ORs \[[@B12]\].

Lactate has also been widely studied as a biomarker of the outcomes of a series of disease related to tissue hypoxia, sepsis, and organ failure \[[@B1], [@B3]--[@B5], [@B7]--[@B10], [@B17], [@B22]\]. Bakker et al. reported that patients with lower organ failure scores had a lower initial blood lactate level and a shorter duration of lactic acidosis, while patients who died during the first 24 hours had a higher initial blood lactate level and a longer duration of lactic acidosis \[[@B9]\]. Amorini et al. utilized serum lactate as a monitoring of "virtual hypoxia" in multiple sclerosis patients and a secondary outcome for treatment trials aimed at improving mitochondrial function in patients with multiple sclerosis \[[@B10]\]. Krinsley et al. demonstrated that the hypoglycemia could be the result of impaired renal and liver function which affects outcomes \[[@B4]\]. Filho et al. reported the utilization of cerebrospinal fluid (CSF) lactate as a potential biomarker to distinguish between children with bacterial and aseptic meningitis \[[@B5]\]. Mokline et al. reported that the plasma lactate could be used as a powerful predictor biomarker of sepsis and mortality in burn patients. An initial lactate value of 4 mmol/L provided the best sensitivity (88%) and specificity (79%), and the cutoff value for mortality prediction was 4.46 mmol/L with a good sensitivity (86%) and specificity (92%) \[[@B3]\]. Mikkelsen et al. demonstrated that the initial serum lactate was associated with mortality in patients admitted to the ED with severe sepsis \[[@B8]\]. Shapiro et al. demonstrated that lactate level greater than or equal to 4.0 mmol/L had good sensitivity and specificity to predict the mortality within 3 days \[[@B7]\].

Many effects have been done in investigating the relations of lactate and glucose with the outcomes of ICU patients; however, the combined effect of glucose and lactate has rarely been well studied. A recent study conducted by Jorge et al. investigated the relation between the combined glucose/lactate and mortality as well as organ failure. They found that the combination of the highest lactate quintile with the lowest glucose quintile was associated with the highest rates of renal dysfunction, liver dysfunction, and mortality \[[@B11]\]. In addition to glucose, interactions between lactate and other parameters have also been studied. Ospina-Tascón et al. demonstrated that the combined Cv-aCO~2~/Da-vO~2~ ratio with lactate levels could better identify patients at a high risk of adverse outcomes during early stages of resuscitation of septic shock \[[@B23]\]. Ho and Lan reported that combining the qSOFA score with plasma lactate had a predictive ability comparable to the standard SOFA score \[[@B24]\].

Our study substantially extends these previous investigations and presented a comprehensive view of how the overall glycometabolic metabolism affects the outcomes of ICU patients. We demonstrated that prediction of in-hospital mortality of ICU patient is glycometabolism related rather than only lactate related. Neither glucose nor lactate could be used as a predictor of the in-hospital mortality independently. In the low- and high-glucose groups, lactate was associated significantly with in-hospital mortality, whereas in the medium-glucose group, lactate was inadequate to provide a good prediction of in-hospital mortality and other well-accepted indexes such as the APACHE II score and SOFA score should be utilized to obtain a more reasonable and accurate assessment of in-hospital mortality.

Nevertheless, some limitations could still be seen in our study. Due to the small number of clinical samples, selection bias might be inevitable and influence the statistical results. It is interesting to note that in the low- (less than 7 mmol/L) glucose group, diabetes mellitus has a near significant *p* value (0.053), indicating that at low glucose levels, diabetes mellitus may be also associated with the in-hospital mortality. This finding is consistent with previous demonstration that the low glucose is associated with the higher risk of death \[[@B25]--[@B27]\]. Therefore, we envisioned that with larger populations, a more reasonable and comprehensive demonstration could be generated. Moreover, as it is retrospective and one center study, prospective and multicenter researches would be required in the future to further validate our conclusions.

5. Conclusion {#sec5}
=============

In conclusion, our results showed that the predictive ability of lactate to assess in-hospital mortality also depended on glucose levels. In low and high glucose levels, lactate level would provide a good prediction of in-hospital mortality while in the medium glucose level, the APACHE II score or SOFA score could provide a more accurate and more comprehensive prediction of in-hospital mortality.
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ARDS:

:   Acute respiratory distress syndrome
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DE:

:   Emergency department

DIC:

:   Disseminated intravascular coagulation

ICU:

:   Intensive care unit

MOF:

:   Multiple organ failure
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:   Quick Sequential Organ Failure Assessment
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:   Receiver operating characteristic curve
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Table S1: patient number of 6 subgroups.

###### 

Click here for additional data file.

![ROC of lactate, glucose, APACHE II score, SOFA score, and qSOFA score. The ROC of the five indexes were plotted, and their AUROC were compared. AUROC of lactate, glucose, APACHE II score, SOFA score, and qSOFA score were 0.678, 0.472, 0.675, 0.736, and 0.605, respectively.](DM2019-1578502.001){#fig1}

![Combined effect of lactate and glucose on in-hospital mortality. The highest mortality was observed in the group with the lowest glucose level and the highest lactate level.](DM2019-1578502.002){#fig2}

![ROC of lactate in the three glucose groups: (a) the ROC of lactate in the low-glucose group (glucose \< 7 mmol/L) with an AUROC of 0.723; (b) the ROC of lactate in the medium-glucose group (7 mmol/L ≤ glucose ≤ 9 mmol/L) with an AUROC of 0.603; (c) the ROC of lactate in the high-glucose group (glucose \> 9 mmol/L) with an AUROC of 0.677.](DM2019-1578502.003){#fig3}

![ROC of the APACHE II score, SOFA score, and qSOFA in the three glucose groups: (a) in the low-glucose group (glucose \< 7 mmol/L), the AUROC of the APACHE II score, SOFA score, and qSOFA score were 0.650, 0.779, and 0.574, respectively; (b) in the medium-glucose group (7 mmol/L ≤ glucose ≤ 9 mmol/L), the AUROC of the APACHE II score, SOFA score, and qSOFA score were 0.723, 0.700, and 0.629, respectively; (c) in the high-glucose group (glucose \> 9 mmol/L), the AUROC of the APACHE II score, SOFA score, and qSOFA score were 0.690, 0.712, and 0.652, respectively.](DM2019-1578502.004){#fig4}

###### 

Patient characteristics, reason for ICU admission and comorbidities.

  -------------------------------------------------------------------------------------------------------------
  Variable                         All patients\   Hospital survivors\   Hospital nonsurvivors\   *p* value
                                   (*n* = 293)     (*n* = 234)           (*n* = 59)               
  -------------------------------- --------------- --------------------- ------------------------ -------------
  Age                              61.44           60.87                 63.71                    0.306

  Male                             62.8% (184)     62.7% (147)           62.8% (37)               0.988

  Reason for ICU admission                                                                        

   Cardiovascular disease          17.4% (51)      15.4% (36)            25.4% (15)               0.069

   Gastrointestinal disease        27.6% (81)      25.6% (60)            35.6% (21)               0.127

   Neurological disease            14.7% (43)      13.7% (32)            18.6% (11)               0.335

   Respiratory disease             26.3% (77)      25.6% (60)            28.8% (17)               0.621

   Surgery                         34.5% (101)     34.6% (81)            33.9% (20)               0.918

   Sepsis                          13.7% (40)      14.1% (33)            11.9% (7)                0.655

   Trauma                          10.6% (31)      11.5% (27)            6.8% (4)                 0.288

   Other                           6.5% (19)       5.1% (12)             11.9% (7)                0.060

  Comorbidities                                                                                   

   ACS                             10.6% (31)      9.4% (22)             15.3% (9)                0.192

   AKI                             16.7% (49)      17.1% (40)            15.3% (9)                0.735

   ALI                             10.6% (31)      10.3% (24)            11.9% (7)                0.720

   ARDS                            13.3% (39)      12.4% (29)            16.9% (10)               0.357

   Cirrhosis                       8.9% (26)       9.4% (22)             6.8% (4)                 0.572

   Diabetes mellitus               14.0% (41)      11.5% (27)            23.7% (14)               **0.016**

   DIC                             1.4% (4)        1.3% (3)              1.7% (1)                 0.807

   Drinking                        22.5% (69)      25.6% (60)            10.2% (9)                0.093

   Hypertension                    28.3% (83)      29.1% (68)            25.4% (15)               0.580

   Malignant disease               22.1% (65)      21.8% (51)            23.7% (14)               0.749

   MOF                             16.7% (49)      14.1% (33)            27.1% (16)               **0.017**

   Smoking                         32.4% (95)      34.2% (80)            25.4% (15)               0.199

   Stroke                          13.0% (38)      12.8% (30)            13.6% (8)                0.880

  APACHE II at ICU admission       16.55           15.46                 20.90                    **\<0.001**

  Glucose level at ICU admission   8.02            8.06                  7.85                     0.505

  Lactate level at ICU admission   3.82            2.81                  5.64                     **\<0.001**

  qSOFA score at ICU admission     1.29            1.06                  1.39                     **0.008**

  SOFA score at ICU admission      8.02            7.33                  10.76                    **\<0.001**

  Length of ICU stay               14.62           13.91                 17.42                    0.355
  -------------------------------------------------------------------------------------------------------------

*p* values generated by either Mann--Whitney or *χ*^2^ test. ACS: acute coronary syndrome; AKI: acute kidney injury; ALI: acute lung injury; ARDS: acute respiratory distress syndrome; DIC: disseminated intravascular coagulation; IHD: ischemic heart disease; APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment; qSOFA: Quick Sequential Organ Failure Assessment.

###### 

Univariate and multivariate analyses of in-hospital mortality.

  Variable                    Univariable regression   Multivariable regression                         
  --------------------------- ------------------------ -------------------------- --------------------- -----------
  Age                         1.010 (0.993-1.027)      0.266                                            
  Gender                      0.995 (0.551-1.797)      0.988                                            
  Reason for ICU admission                                                                              
   Cardiovascular disease     1.875 (0.945-3.720)      0.072                                            
   Gastrointestinal disease   0.624 (0.240-1.147)      0.129                                            
   Neurological disease       1.447 (0.681-3.074)      0.337                                            
   Respiratory disease        1.174 (0.622-1.174)      0.621                                            
   Surgery                    0.969 (0.530-1.770)      0.918                                            
   Sepsis                     0.820 (0.343-1.959)      0.655                                            
   Trauma                     0.558 (0.187-1.661)      0.294                                            
   Other                      2.490 (0.935-6.634)      0.068                                            
  Comorbidities                                                                                         
   ACS                        1.735 (0.753-3.996)      0.196                                            
   AKI                        0.873 (0.397-1.918)      0.735                                            
   ALI                        1.178 (0.481-2.883)      0.720                                            
   ARDS                       1.443 (0.659-3.158)      0.359                                            
   Cirrhosis                  0.701 (0.232-2.118)      0.529                                            
   Diabetes mellitus          2.385 (1.159-4.908)      **0.018**                  2.326 (1.055-5.130)   **0.036**
   DIC                        1.328 (1.36-12.998)      0.808                                            
   Drinking                   0.522 (0.242-1.125)      0.097                                            
   Hypertension               0.832 (0.434-1.595)      0.580                                            
   Malignant disease          1.116 (0.568-2.193)      0.749                                            
   MOF                        2.266 (1.146-4.482)      **0.019**                  1.265 (0.590-2.715)   0.545
   Smoking                    0.656 (0.344-1.251)      0.201                                            
   Stroke                     1.067 (0.461-2.466)      0.880                                            
  APACHE II                   1.093 (1.052-1.135)      **\<0.001**                1.065 (1.007-1.128)   **0.027**
  Glucose                     0.990 (0.928-1.056)      0.795                                            
  Lactate                     1.131 (1.065-1.200)      **\<0.001**                1.093 (1.024-1.168)   **0.008**
  qSOFA                       1.547 (1.108-2.159)      **0.010**                  0.855 (0.545-1.343)   0.497
  SOFA                        1.160 (1.083-1.242)      **\<0.001**                1.057 (0.979-1.142)   0.157

###### 

Univariable and multivariable analysis of in-hospital mortality based on glucose levels.

###### 

\(a\) Glucose \< 7 mmol/L

  Variable                    Univariable regression   Multivariable regression                         
  --------------------------- ------------------------ -------------------------- --------------------- -----------
  Age                         0.507 (0.221-1.163)      0.109                                            
  Gender                      0.492 (0.214-1.132)      0.095                                            
  Reason for ICU admission                                                                              
   Cardiovascular disease     1.796 (0.701-4.601)      0.222                                            
   Gastrointestinal disease   0.879 (0.364-2.121)      0.773                                            
   Neurological disease       0.969 (0.300-3.315)      0.959                                            
   Respiratory disease        1.447 (0.609-3.441)      0.403                                            
   Surgery                    1.360 (0.593-3.118)      0.467                                            
   Sepsis                     1.040 (0.320-3.383)      0.948                                            
   Trauma                     0.519 (0.112-2.406)      0.402                                            
   Other                      2.917 (0.877-9.695)      0.081                                            
  Comorbidities                                                                                         
   ACS                        0.914 (0.187-4.475)      0.911                                            
   AKI                        1.162 (0.423-3.192)      0.771                                            
   ALI                        0.874 (0.234-3.266)      0.841                                            
   ARDS                       2.619 (0.938-7.314)      0.066                                            
   Cirrhosis                  0.393 (0.048-3.199)      0.383                                            
   Diabetes mellitus          3.363 (0.984-11.498)     0.053                                            
   DIC                        4.250 (0.258-70.045)     0.312                                            
   Drinking                   0.180 (0.041-0.798)      **0.024**                  0.157 (0.018-1.399)   0.097
   Hypertension               0.634 (0.238-1.690)      0.362                                            
   Malignant disease          2.308 (0.882-6.043)      0.089                                            
   MOF                        2.550 (1.003-6.481)      **0.049**                  1.443 (0.475-4.386)   0.517
   Smoking                    0.365 (0.139-0.962)      **0.042**                  0.484 (0.115-2.041)   0.323
   Stroke                     0.613 (0.169-2.232)      0.458                                            
  APACHE II                   1.083 (1.027-1.142)      **0.003**                  1.043 (0.969-1.123)   0.262
  Lactate                     1.126 (1.042-1.216)      **0.003**                  1.093 (1.007-1.188)   **0.035**
  qSOFA                       1.356 (0.862-2.132)      0.188                                            
  SOFA                        1.147 (1.043-1.262)      **0.005**                  1.104 (1.006-1.210)   **0.036**

###### 

\(b\) 7 mmol/L ≤ glucose ≤ 9 mmol/L

  Variable                    Univariable regression   Multivariable regression                         
  --------------------------- ------------------------ -------------------------- --------------------- -------
  Age                         0.507 (0.221-1.163)      0.109                                            
  Gender                      1.067 (0.301-3.785)      0.920                                            
  Reason for ICU admission                                                                              
   Cardiovascular disease     1.387 (0.310-6.216)      0.669                                            
   Gastrointestinal disease   0.312 (0.087-1.115)      0.073                                            
   Neurological disease       2.400 (0.489-11.772)     0.281                                            
   Respiratory disease        0.927 (0.216-3.986)      0.919                                            
   Surgery                    0.732 (0.195-2.749)      0.644                                            
   Sepsis                     0.542 (0.059-4.956)      0.587                                            
   Trauma                     0.841 (0.155-4.554)      0.841                                            
   Other                      ---                      ---                                              
  Comorbidities                                                                                         
   ACS                        1.629 (0.356-7.456)      0.530                                            
   AKI                        0.987 (0.179-5.450)      0.988                                            
   ALI                        4.200 (0.735-23.991)     0.107                                            
   ARDS                       0.841 (0.155-4.554)      0.841                                            
   Cirrhosis                  0.854 (0.087-8.383)      0.892                                            
   Diabetes mellitus          2.891 (0.747-11.192)     0.124                                            
   DIC                        ---                      ---                                              
   Drinking                   0.727 (0.136-3.880)      0.709                                            
   Hypertension               0.738 (0.175-3.124)      0.680                                            
   Malignant disease          0.137 (0.016-1.152)      0.067                                            
   MOF                        2.889 (0.672-12.415)     0.154                                            
   Smoking                    1.556 (0.395-6.131)      0.528                                            
   Stroke                     3.909 (0.494-30.942)     0.197                                            
  APACHE II                   1.144 (1.027-1.142)      **0.005**                  1.126 (0.982-1.290)   0.089
  Lactate                     1.168 (0.928-1.470)      0.186                                            
  qSOFA                       1.953 (0.891-4.279)      0.095                                            
  SOFA                        1.229 (1.033-1.463)      **0.020**                  1.041 (0.812-1.333)   0.753

###### 

\(c\) Glucose \> 9 mmol/L

  Variable                    Univariable regression   Multivariable regression                         
  --------------------------- ------------------------ -------------------------- --------------------- -------
  Age                         1.019 (0.984-1.050)      0.288                                            
  Gender                      3.250 (0.965-10.950)     0.057                                            
  Reason for ICU admission                                                                              
   Cardiovascular disease     2.813 (0.718-11.021)     0.138                                            
   Gastrointestinal disease   0.698 (0.214-2.278)      0.552                                            
   Neurological disease       1.877 (0.509-6.921)      0.344                                            
   Respiratory disease        0.977 (0.281-3.398)      0.971                                            
   Surgery                    0.642 (0.188-2.188)      0.479                                            
   Sepsis                     0.727 (0.145-3.636)      0.698                                            
   Trauma                     0                        0.999                                            
   Other                      1.047 (0.109-10.014)     0.968                                            
  Comorbidities                                                                                         
   ACS                        3.333 (0.823-13.494)     0.091                                            
   AKI                        0.341 (0.041-2.840)      0.320                                            
   ALI                        0.571 (0.066-4.983)      0.613                                            
   ARDS                       0.492 (0.057-4.226)      0.518                                            
   Cirrhosis                  1.050 (0.202-5.460)      0.954                                            
   Diabetes mellitus          1.513 (0.420-5.447)      0.526                                            
   DIC                        0                        0.999                                            
   Drinking                   1.432 (0.439-4.673)      0.552                                            
   Hypertension               1.391 (0.453-4.268)      0.564                                            
   Malignant disease          1.324 (0.408-4.295)      0.641                                            
   MOF                        1.476 (0.353-6.166)      0.593                                            
   Smoking                    1.062 (0.332-3.404)      0.919                                            
   Stroke                     1.476 (0.353-6.166)      0.593                                            
  APACHE II                   1.087 (1.017-1.161)      **0.014**                  1.056 (0.962-1.158)   0.252
  Lactate                     1.154 (1.035-1.285)      **0.010**                  1.118 (0.997-1.255)   0.057
  qSOFA                       1.783 (0.940-3.383)      0.077                                            
  SOFA                        1.157 (1.026-1.305)      **0.017**                  1.039 (0.876-1.233)   0.658

[^1]: Academic Editor: Carlo Chiarla
